A Whole-Mount Organ Staining Technique for Three-Dimensional Imaging of the Kidney
JoVE Encyclopedia of Experiments
Immunology
0 views • 3:43 min • July 8th, 2025
Loading...
Overview
This article describes a method for enhancing the transparency of fixed mouse kidney tissue to visualize sympathetic nerve distribution using light-sheet fluorescence microscopy. The process involves delipidation and decolorization using CUBIC-L, followed by immunostaining and refractive index matching with CUBIC-R+.
Key Study Components
Area of Science
- Neuroscience
- Histology
- Immunohistochemistry
Background
- Light scattering and absorption in tissue can obscure cellular structures.
- CUBIC-L and CUBIC-R+ are chemical solutions used to enhance tissue transparency.
- Immunostaining allows for the visualization of specific proteins in tissues.
- Light-sheet fluorescence microscopy is a technique for capturing three-dimensional images of biological samples.
Purpose of Study
- To develop a protocol for visualizing sympathetic nerve distribution in kidney tissue.
- To improve tissue transparency for better imaging results.
- To demonstrate the effectiveness of CUBIC-L and CUBIC-R+ in tissue preparation.
Methods Used
- Fixed mouse kidney tissue was treated with CUBIC-L for delipidation and decolorization.
- Primary antibodies were introduced to bind specific neuronal and muscle cell markers.
- Secondary antibodies labeled with fluorophores were used for visualization.
- Light-sheet fluorescence microscopy was employed to capture three-dimensional images.
Main Results
- The delipidation and decolorization process significantly increased tissue transparency.
- Successful immunostaining allowed for clear visualization of sympathetic nerves around kidney arteries.
- Three-dimensional imaging provided detailed insights into nerve distribution.
- The protocol demonstrated reproducibility and effectiveness for similar studies.
Conclusions
- The combination of CUBIC-L and CUBIC-R+ is effective for enhancing tissue transparency.
- This method can be applied to other tissues for improved imaging of cellular structures.
- Light-sheet fluorescence microscopy is a powerful tool for studying complex tissue architectures.
Frequently Asked Questions
What is the main advantage of using CUBIC-L?
CUBIC-L effectively removes lipids and pigments, enhancing tissue transparency for better imaging.
How does light-sheet fluorescence microscopy work?
It uses thin sheets of light to illuminate samples, allowing for high-resolution three-dimensional imaging.
What types of tissues can this method be applied to?
This method can be adapted for various tissues, particularly those requiring enhanced transparency for imaging.
What are the key steps in the delipidation process?
The key steps include immersion in CUBIC-L, gentle shaking, and repeated washes with PBS.
Why is refractive index matching important?
It minimizes light scattering, improving the quality of the images captured during microscopy.
Executive Industry Relevance
This tissue-clearing and imaging approach enables high-resolution three-dimensional visualization of sympathetic innervation and vascular architecture in whole organs, supporting mechanistic de-risking in target validation studies. By providing quantitative spatial mapping of neurovascular interactions, the method enhances predictive confidence in preclinical models of renal and cardiovascular disease. The protocol’s reproducibility and scalability facilitate cross-functional collaboration between discovery biology, imaging, and translational teams.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Enables interrogation of therapeutic hypotheses by visualizing sympathetic nerve patterning around renal arteries in intact tissue.
- Operational Value: Supports biological de-risking through direct observation of target engagement in neurovascular units.
- Predictive Value: Improves portfolio triage by revealing off-target innervation effects that may confound drug safety assessments.
Screening & Assay Development
- Assay Readiness: Generates standardized, transparent kidney preparations suitable for multiplexed immunostaining and automated imaging workflows.
- Quantitative Output: Produces three-dimensional fluorescence readouts enabling morphometric analysis of nerve density and vascular proximity.
- Platform Reuse: Establishes a reusable tissue-clearing foundation for downstream screening of compounds affecting renal innervation or vascular tone.
Translational & Preclinical Research
- Disease Relevance: Models sympathetic overactivity in hypertension and diabetic nephropathy through spatial nerve-artery mapping.
- Translational Continuity: Bridges discovery imaging with preclinical validation by preserving neurovascular architecture for longitudinal studies.
- Risk-Adjusted Decisions: Supports go/no-go criteria based on quantifiable changes in sympathetic remodeling following intervention.
Pipeline & Workflow Integration
The method fits within the discovery continuum from target validation through lead optimization, particularly for compounds modulating autonomic nervous system activity in the kidney.
- Discovery Biology: Facilitates hypothesis testing of neural mechanisms in renal pathophysiology via direct tissue visualization.
- Screening: Enables assay standardization through reproducible clearing and staining, supporting reliable compound screening campaigns.
- Analytics: Delivers spatial fluorescence measurements and co-localization metrics that allow objective comparison of experimental conditions.
- Translational Research: Maintains structural continuity from discovery to preclinical by preserving three-dimensional neurovascular context.
- Enterprise Reuse: Functions as a scalable imaging platform applicable across multiple organ systems and therapeutic areas.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence by reducing mechanistic ambiguity in neurovascular target validation.
- Operational Value: Ensures standardization and reproducibility across laboratories through defined clearing and staining parameters.
- Strategic Value: Improves capital efficiency by enabling early detection of off-target neural effects, reducing late-stage attrition.
- Portfolio Impact: Informs risk-adjusted prioritization by quantifying target-mediated changes in renal innervation patterns.
Implementation Considerations
- Requires expertise in immunohistochemistry, tissue handling, and fluorescence microscopy.
- Dependent on access to light-sheet or confocal microscopy systems and optical clearing reagents.
- Necessitates cross-team standardization of staining protocols, antibody validation, and imaging parameters.
- Involves adaptation considerations when extending the method to human or larger mammalian kidney samples.
- Limited by tissue size and antibody penetration depth, which may affect staining uniformity in larger organs.
Biopharma FAQs
Why does whole-mount kidney staining matter for target validation?
It enables direct visualization of target protein expression in sympathetic nerves and vascular structures within intact tissue, supporting mechanistic de-risking by confirming on-target engagement in neurovascular units without sectioning artifacts.
How does isolating sympathetic innervation as an independent variable support discovery pipeline decisions?
By staining for tyrosine hydroxylase and alpha-smooth muscle actin, the method isolates sympathetic nerve contribution to vascular tone, allowing researchers to assess how specific targets modulate nerve-artery interactions in preclinical models.
What quantitative measurements from three-dimensional imaging enable lead identification?
The technique provides spatial metrics such as nerve density, proximity to arteries, and branching patterns, which serve as quantitative readouts to compare compound effects on renal innervation during lead optimization.
Why are replication requirements critical for cross-functional collaboration in imaging-based assays?
Standardized clearing, staining, and imaging steps ensure reproducible three-dimensional data across teams, enabling discovery biology, pharmacology, and safety groups to compare results using consistent neurovascular benchmarks.
What statistical analysis capabilities are required before implementing this imaging method in drug discovery?
Implementation requires spatial statistics tools to analyze nerve distribution, co-localization coefficients, and morphometric changes, enabling objective comparison of treatment groups and supporting go/no-go decisions based on predefined effect thresholds.
07:46
ACT-PRESTO: Biological Tissue Clearing and Immunolabeling Methods for Volume Imaging
Related Videos
0 Views
10:40
Single-Cell Resolution Three-Dimensional Imaging of Intact Organoids
Related Videos
0 Views
08:17
Quantitative 3D Imaging of Trypanosoma cruzi-Infected Cells, Dormant Amastigotes, and T Cells in Intact Clarified Organs
Related Videos
0 Views
02:57
Kidney Flat Mount Preparation: A Procedure to Dissect and Prepare a Flat Mount for Microscopic Analysis of Adult Zebrafish Kidney
Related Videos
0 Views
06:43
Fluid Aspiration from Mouse Glomeruli: A Method to Aspirate Glomerular Fluid from Mouse Using Two-Photon Mediated Micropuncture
Related Videos
0 Views
03:14
Eosin Staining of Soft-Tissue Samples: An Eosin-Based Procedure for Whole Mouse Kidney Staining to Visualize Specific Tissue Microstructures
Related Videos
0 Views
06:18
Optical Clearing and Imaging of Immunolabeled Kidney Tissue
Related Videos
0 Views
07:01
3D Imaging of Soft-Tissue Samples using an X-ray Specific Staining Method and Nanoscopic Computed Tomography
Related Videos
0 Views
12:49
Optimization of Renal Organoid and Organotypic Culture for Vascularization, Extended Development, and Improved Microscopy Imaging
Related Videos
0 Views
07:38
Isolating and Imaging Live, Intact Pacemaker Regions of Mouse Renal Pelvis by Vibratome Sectioning
Related Videos
0 Views
Last updated: 15 August 2026